JP2023553094A5 - - Google Patents
Info
- Publication number
- JP2023553094A5 JP2023553094A5 JP2023534880A JP2023534880A JP2023553094A5 JP 2023553094 A5 JP2023553094 A5 JP 2023553094A5 JP 2023534880 A JP2023534880 A JP 2023534880A JP 2023534880 A JP2023534880 A JP 2023534880A JP 2023553094 A5 JP2023553094 A5 JP 2023553094A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- substituted
- atoms
- alkyl
- hydrogen atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122181P | 2020-12-07 | 2020-12-07 | |
| US63/122,181 | 2020-12-07 | ||
| PCT/CA2021/051755 WO2022120475A1 (en) | 2020-12-07 | 2021-12-07 | 3-cyclic amine-indole derivatives as serotonergic agents for the treatment of cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553094A JP2023553094A (ja) | 2023-12-20 |
| JP2023553094A5 true JP2023553094A5 (cg-RX-API-DMAC10.html) | 2024-12-06 |
Family
ID=81973031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534880A Pending JP2023553094A (ja) | 2020-12-07 | 2021-12-07 | 中枢神経系障害の治療のためのセロトニン作動性薬としての３位環－アミンインドール誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240051978A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4255913A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023553094A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230117597A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116917305A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021394129A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3201080A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL303467A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023006652A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022120475A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519816A4 (en) | 2016-09-29 | 2020-05-06 | The Regents of the University of California | CONNECTIONS FOR INCREASING NEURONAL PLASTICITY |
| KR102946120B1 (ko) | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| WO2022221415A2 (en) | 2021-04-13 | 2022-10-20 | The Regents Of The University Of California | Tetracyclic compounds for treating brain disorders |
| KR20240017363A (ko) * | 2021-06-02 | 2024-02-07 | 세인트 조셉스 유니버시티 | 플루오린화 트립타민 화합물, 이의 유사체 및 이를 사용하는 방법 |
| JP2025502615A (ja) | 2021-12-15 | 2025-01-28 | デリックス セラピューティクス，インク． | フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用 |
| EP4447954A4 (en) * | 2021-12-16 | 2025-12-03 | Icahn School Med Mount Sinai | HETEROCYCLIC COMPOUNDS AS POLARIZED 5HT2A AGONISTS |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| EP4551211A1 (en) * | 2022-07-08 | 2025-05-14 | Institut Curie | Serotonin analogues for use in treating metalloptosis-associated disorders |
| US12396981B2 (en) | 2023-03-09 | 2025-08-26 | William Shulman | Methods of using DMT |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789402A (en) * | 1995-01-17 | 1998-08-04 | Eli Lilly Company | Compounds having effects on serotonin-related systems |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| US6133287A (en) * | 1998-03-24 | 2000-10-17 | Allelix Biopharmaceuticals Inc. | Piperidine-indole compounds having 5-HT6 affinity |
| GB9810886D0 (en) * | 1998-05-13 | 1998-07-22 | Lilly Industries Ltd | Pharmaceutical compounds |
| EP1173432B9 (en) * | 1999-04-21 | 2008-10-15 | NPS Allelix Corp. | Piperidine-indole compounds having 5-ht6 affinity |
| EA200300717A1 (ru) * | 2000-12-22 | 2003-12-25 | Уайт | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов |
| WO2004069828A1 (ja) * | 2003-02-04 | 2004-08-19 | Mitsubishi Pharma Corporation | ピペリジン化合物およびその医薬用途 |
| WO2005066157A1 (en) * | 2004-01-02 | 2005-07-21 | Suven Life Sciences | 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
| EP1984351A1 (en) * | 2006-02-17 | 2008-10-29 | Memory Pharmaceuticals Corporation | Compounds having 5-ht6 receptor affinity |
| US8912220B2 (en) * | 2009-08-10 | 2014-12-16 | Galenea Pharmaceuticals | Compounds and methods of use thereof |
| US20230405026A1 (en) * | 2020-11-06 | 2023-12-21 | Mynd Life Sciences Inc. | A Method of Treating Depression by Immune Modulation |
-
2021
- 2021-12-07 US US18/265,286 patent/US20240051978A1/en active Pending
- 2021-12-07 JP JP2023534880A patent/JP2023553094A/ja active Pending
- 2021-12-07 AU AU2021394129A patent/AU2021394129A1/en active Pending
- 2021-12-07 KR KR1020237023111A patent/KR20230117597A/ko active Pending
- 2021-12-07 EP EP21901751.4A patent/EP4255913A4/en active Pending
- 2021-12-07 IL IL303467A patent/IL303467A/en unknown
- 2021-12-07 CA CA3201080A patent/CA3201080A1/en active Pending
- 2021-12-07 CN CN202180092982.XA patent/CN116917305A/zh active Pending
- 2021-12-07 MX MX2023006652A patent/MX2023006652A/es unknown
- 2021-12-07 WO PCT/CA2021/051755 patent/WO2022120475A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513679A5 (cg-RX-API-DMAC10.html) | ||
| JP2023512821A5 (cg-RX-API-DMAC10.html) | ||
| IL295371A (en) | Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders | |
| JP5791612B2 (ja) | ピリド［３，４−ｂ］インドールおよび使用方法 | |
| JP5586577B2 (ja) | 架橋複素環化合物およびその使用 | |
| CN102480956B (zh) | 吡啶并[4,3-b]吲哚类和使用方法 | |
| JP5779183B2 (ja) | ピリド［４，３−ｂ］インドールおよび使用方法 | |
| JP2024508922A5 (cg-RX-API-DMAC10.html) | ||
| JP5869484B2 (ja) | 架橋複素環化合物およびその使用 | |
| JP6933964B2 (ja) | ヘテロアリール化合物およびそれらの使用方法 | |
| JP6421185B2 (ja) | ベンゾイミダゾール−プロリン誘導体の使用 | |
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| JP2024508545A5 (cg-RX-API-DMAC10.html) | ||
| JP2023553094A (ja) | 中枢神経系障害の治療のためのセロトニン作動性薬としての３位環－アミンインドール誘導体 | |
| JP2019534327A5 (cg-RX-API-DMAC10.html) | ||
| CA3210275A1 (en) | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto | |
| JP2025513462A5 (cg-RX-API-DMAC10.html) | ||
| EP4144725A1 (en) | 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof | |
| IL316416A (en) | Indoline derivatives as estrogenic agents for the treatment of disorders | |
| JP2025513461A5 (cg-RX-API-DMAC10.html) | ||
| RU2004100310A (ru) | Производные бензоксазепина и их использование в качестве стимуляторов рецептора амра | |
| JP2019535715A5 (cg-RX-API-DMAC10.html) | ||
| FI3541784T3 (fi) | Uudet atsetidiinijohdannaiset, jotka ovat hyödyllisiä kortikaalisen katekoliamiini-neurotransmission modulaattoreina | |
| JP2005508352A5 (cg-RX-API-DMAC10.html) | ||
| RU2008102154A (ru) | ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ-АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТ6 РЕЦЕПТОРОВ, ЛЕКАРСТВЕННАЯ СУБСТАНЦИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННЫЙ ПРЕПАРАТ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ |